Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Eli Lilly and Co US: News Biotechnology
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Breaking News: Markets Health care industry Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags General Motors Co Investing Bristol/Myers Squibb Co
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Companies Moderna Inc Merck & Co Inc
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Business Biotechnology Eli Lilly and Co
From CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Breaking News: Investing Investment strategy Kraft Heinz Co
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Health & Science Thermo Fisher Scientific Inc stocks
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Eisai Co Ltd Biotechnology Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Politics Markets Investment strategy
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Health & Science Business Biotechnology
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Companies Breaking news Health care industry
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Health care industry Companies Cigna Corp
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags US Economy Politics Markets
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags U/S/ Markets Investment Strategy Mad Money
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Health & Science Eisai Co Ltd Biotechnology
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Biotechnology Business Health & Science
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Health care industry Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Business Stock markets Eli Lilly and Co
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Breaking news Companies Pfizer Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Novo Nordisk A/S Business
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Health care industry Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Mad Money Investment strategy Markets
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Autozone Inc U/S/ Markets Snowflake Inc/
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Breaking news Companies Social issues
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Health & Science Biotechnology Business
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Pfizer Inc Health care industry Breaking news
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Europe News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.